Cargando…
2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension
The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been established. It is confirmed that higher blood pressure levels are associated with increased ri...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670210/ https://www.ncbi.nlm.nih.gov/pubmed/31388451 http://dx.doi.org/10.1186/s40885-019-0121-0 |
_version_ | 1783440518157434880 |
---|---|
author | Kim, Hyeon Chang Ihm, Sang-Hyun Kim, Gheun-Ho Kim, Ju Han Kim, Kwang-il Lee, Hae-Young Lee, Jang Hoon Park, Jong-Moo Park, Sungha Pyun, Wook Bum Shin, Jinho Chae, Shung Chull |
author_facet | Kim, Hyeon Chang Ihm, Sang-Hyun Kim, Gheun-Ho Kim, Ju Han Kim, Kwang-il Lee, Hae-Young Lee, Jang Hoon Park, Jong-Moo Park, Sungha Pyun, Wook Bum Shin, Jinho Chae, Shung Chull |
author_sort | Kim, Hyeon Chang |
collection | PubMed |
description | The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been established. It is confirmed that higher blood pressure levels are associated with increased risk of cardiovascular disease and mortality also in the Korean population. About one third of Korean adults aged 30 years or older are estimated to have hypertension, and the prevalence of hypertension gradually increases as the age increases. The awareness, treatment, and control rates of hypertension are generally improving in Korea, but more efforts are required to increase awareness and treatment among younger patients with hypertension and to improve lifestyle modification compliance at all ages. More studies are required to determine the magnitude and impact of white coat hypertension and masked hypertension in the Korean population. |
format | Online Article Text |
id | pubmed-6670210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66702102019-08-06 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension Kim, Hyeon Chang Ihm, Sang-Hyun Kim, Gheun-Ho Kim, Ju Han Kim, Kwang-il Lee, Hae-Young Lee, Jang Hoon Park, Jong-Moo Park, Sungha Pyun, Wook Bum Shin, Jinho Chae, Shung Chull Clin Hypertens Letter to the Editor The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been established. It is confirmed that higher blood pressure levels are associated with increased risk of cardiovascular disease and mortality also in the Korean population. About one third of Korean adults aged 30 years or older are estimated to have hypertension, and the prevalence of hypertension gradually increases as the age increases. The awareness, treatment, and control rates of hypertension are generally improving in Korea, but more efforts are required to increase awareness and treatment among younger patients with hypertension and to improve lifestyle modification compliance at all ages. More studies are required to determine the magnitude and impact of white coat hypertension and masked hypertension in the Korean population. BioMed Central 2019-08-01 /pmc/articles/PMC6670210/ /pubmed/31388451 http://dx.doi.org/10.1186/s40885-019-0121-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Kim, Hyeon Chang Ihm, Sang-Hyun Kim, Gheun-Ho Kim, Ju Han Kim, Kwang-il Lee, Hae-Young Lee, Jang Hoon Park, Jong-Moo Park, Sungha Pyun, Wook Bum Shin, Jinho Chae, Shung Chull 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension |
title | 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension |
title_full | 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension |
title_fullStr | 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension |
title_full_unstemmed | 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension |
title_short | 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension |
title_sort | 2018 korean society of hypertension guidelines for the management of hypertension: part i-epidemiology of hypertension |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670210/ https://www.ncbi.nlm.nih.gov/pubmed/31388451 http://dx.doi.org/10.1186/s40885-019-0121-0 |
work_keys_str_mv | AT kimhyeonchang 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT ihmsanghyun 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT kimgheunho 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT kimjuhan 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT kimkwangil 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT leehaeyoung 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT leejanghoon 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT parkjongmoo 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT parksungha 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT pyunwookbum 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT shinjinho 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension AT chaeshungchull 2018koreansocietyofhypertensionguidelinesforthemanagementofhypertensionpartiepidemiologyofhypertension |